Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$1.49B |
| 2 |
Eli Lilly
LLY
|
$784M |
| 3 |
NVIDIA
NVDA
|
$544M |
| 4 |
Spotify
SPOT
|
$510M |
| 5 |
Kenvue
KVUE
|
$493M |
Top Sells
| 1 |
Adobe
ADBE
|
$1.02B |
| 2 |
Thermo Fisher Scientific
TMO
|
$698M |
| 3 |
Danaher
DHR
|
$657M |
| 4 |
Intuit
INTU
|
$622M |
| 5 |
Boston Scientific
BSX
|
$562M |
Sector Composition
| 1 | Technology | 21.36% |
| 2 | Financials | 17.98% |
| 3 | Healthcare | 14.07% |
| 4 | Industrials | 13.34% |
| 5 | Consumer Discretionary | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Kroger
KR
$45.1B
| $266K | ﹤0.01% |
5,655
-47,145
| -89% | -$2.22M |
|
802
Taylor Morrison
TMHC
$6.67B
| $265K | ﹤0.01% |
+5,432
| New | +$265K |
|
803
Nutanix
NTNX
$18.2B
| $254K | ﹤0.01% |
+9,049
| New | +$254K |
|
804
AT&T
T
$208B
| $250K | ﹤0.01% |
15,704
-101,412
| -87% | -$1.62M |
|
805
Medifast
MED
$153M
| $244K | ﹤0.01% |
2,649
-5
| -0.2% | -$461 |
|
806
iShares ESG Aware MSCI EM ETF
ESGE
$5.1B
| $233K | ﹤0.01% |
+7,367
| New | +$233K |
|
807
Bristol-Myers Squibb
BMY
$96.7B
| $225K | ﹤0.01% |
3,515
-14,860
| -81% | -$950K |
|
|
VGR
808
DELISTED
Vector Group Ltd.
VGR
| $213K | ﹤0.01% |
16,607
-391
| -2% | -$5.01K |
|
809
Nurix Therapeutics
NRIX
$723M
| $208K | ﹤0.01% |
20,806
-490
| -2% | -$4.9K |
|
810
Open Text
OTEX
$8.37B
| $206K | ﹤0.01% |
4,947
-1,786
| -27% | -$74.2K |
|
811
Canadian Imperial Bank of Commerce
CM
$72.9B
| $204K | ﹤0.01% |
4,769
-27,398
| -85% | -$1.17M |
|
812
Emergent Biosolutions
EBS
$418M
| $198K | ﹤0.01% |
26,878
-634
| -2% | -$4.66K |
|
|
DCPH
813
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $186K | ﹤0.01% |
13,219
-311
| -2% | -$4.38K |
|
814
Bioventus
BVS
$471M
| $171K | ﹤0.01% |
59,166
-86,681
| -59% | -$251K |
|
815
Fate Therapeutics
FATE
$115M
| $164K | ﹤0.01% |
34,362
-809
| -2% | -$3.85K |
|
816
Y-mAbs Therapeutics
YMAB
$390M
| $156K | ﹤0.01% |
+22,930
| New | +$156K |
|
817
Alector
ALEC
$282M
| $137K | ﹤0.01% |
22,792
-537
| -2% | -$3.23K |
|
|
TWOU
818
DELISTED
2U, Inc.
TWOU
| $124K | ﹤0.01% |
1,029
-25
| -2% | -$3.02K |
|
819
FibroGen
FGEN
$48.4M
| $63.3K | ﹤0.01% |
937
-17
| -2% | -$1.15K |
|
820
Airbnb
ABNB
$76.5B
| – | – |
-41,333
| Closed | -$5.14M |
|
821
Allison Transmission
ALSN
$7.36B
| – | – |
-30,056
| Closed | -$1.36M |
|
822
Antero Midstream
AM
$8.54B
| – | – |
-59,770
| Closed | -$627K |
|
823
AngioDynamics
ANGO
$432M
| – | – |
-61,878
| Closed | -$640K |
|
824
Apple Hospitality REIT
APLE
$3.05B
| – | – |
-72,160
| Closed | -$1.12M |
|
825
Beam Therapeutics
BEAM
$1.9B
| – | – |
-10,409
| Closed | -$319K |
|